Persistent chronic dyspnoea following COVID-19 infection
N. Shah (London, United Kingdom), R. D'Cruz (London, United Kingdom), E. Suh (London, United Kingdom), A. West (London, United Kingdom), A. Dewar (London, United Kingdom), K. Myall (London, United Kingdom), J. Hall (London, United Kingdom), N. Hart (London, United Kingdom), P. Murphy (London, United Kingdom), B. Mukherjee (London, United Kingdom), G. Kaltsakas (London, United Kingdom)
Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Shah (London, United Kingdom), R. D'Cruz (London, United Kingdom), E. Suh (London, United Kingdom), A. West (London, United Kingdom), A. Dewar (London, United Kingdom), K. Myall (London, United Kingdom), J. Hall (London, United Kingdom), N. Hart (London, United Kingdom), P. Murphy (London, United Kingdom), B. Mukherjee (London, United Kingdom), G. Kaltsakas (London, United Kingdom). Persistent chronic dyspnoea following COVID-19 infection. 3174
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: